Literature DB >> 15163413

Stepwise reprogramming of B cells into macrophages.

Huafeng Xie1, Min Ye, Ru Feng, Thomas Graf.   

Abstract

Starting with multipotent progenitors, hematopoietic lineages are specified by lineage-restricted transcription factors. The transcription factors that determine the decision between lymphoid and myeloid cell fates, and the underlying mechanisms, remain largely unknown. Here, we report that enforced expression of C/EBPalpha and C/EBPbeta in differentiated B cells leads to their rapid and efficient reprogramming into macrophages. C/EBPs induce these changes by inhibiting the B cell commitment transcription factor Pax5, leading to the downregulation of its target CD19, and synergizing with endogenous PU.1, an ETS family factor, leading to the upregulation of its target Mac-1 and other myeloid markers. The two processes can be uncoupled, since, in PU.1-deficient pre-B cells, C/EBPs induce CD19 downregulation but not Mac-1 activation. Our observations indicate that C/EBPalpha and beta remodel the transcription network of B cells into that of macrophages through a series of parallel and sequential changes that require endogenous PU.1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163413     DOI: 10.1016/s0092-8674(04)00419-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  361 in total

Review 1.  Nuclear reprogramming to a pluripotent state by three approaches.

Authors:  Shinya Yamanaka; Helen M Blau
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 2.  Factors and networks that underpin early hematopoiesis.

Authors:  Elinore M Mercer; Yin C Lin; Cornelis Murre
Journal:  Semin Immunol       Date:  2011-09-18       Impact factor: 11.130

3.  Molecular mechanisms in signal transduction and cancer.

Authors:  Johannes L Bos; Boudewijn M T Burgering
Journal:  EMBO Rep       Date:  2004-09       Impact factor: 8.807

Review 4.  A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine.

Authors:  Grace E Asuelime; Yanhong Shi
Journal:  J Mol Cell Biol       Date:  2012-02-27       Impact factor: 6.216

Review 5.  Programming and reprogramming neuronal subtypes in the central nervous system.

Authors:  Caroline Rouaux; Salman Bhai; Paola Arlotta
Journal:  Dev Neurobiol       Date:  2012-07       Impact factor: 3.964

Review 6.  Delineating nuclear reprogramming.

Authors:  Jolene Ooi; Pentao Liu
Journal:  Protein Cell       Date:  2012-03-31       Impact factor: 14.870

7.  Direct reprogramming of melanocytes to neural crest stem-like cells by one defined factor.

Authors:  Susan E Zabierowski; Valerie Baubet; Benjamin Himes; Ling Li; Mizuho Fukunaga-Kalabis; Sonal Patel; Ronan McDaid; Matt Guerra; Phyllis Gimotty; Nadia Dahmane; Nadia Dahamne; Meenhard Herlyn
Journal:  Stem Cells       Date:  2011-11       Impact factor: 6.277

Review 8.  Ovarian cancer stem cells: are they real and why are they important?

Authors:  Monjri M Shah; Charles N Landen
Journal:  Gynecol Oncol       Date:  2013-12-07       Impact factor: 5.482

Review 9.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

10.  Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible.

Authors:  Hiromi Tagoh; Alexandra Schebesta; Pascal Lefevre; Nicola Wilson; David Hume; Meinrad Busslinger; Constanze Bonifer
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.